Brief: Essa Pharma Provides Corporate Update And Reports Financial Results For Q4 And Year Ended September 30 2023

ESSA Pharma

12/12/2023 12:17

Dec 12 (Reuters) - ESSA Pharma Inc  EPIX.O :
    * ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30,
2023
    * ESSA PHARMA INC - AT SEPTEMBER 30, 2023, THE COMPANY HAD
AVAILABLE CASH RESERVES AND SHORT-TERM INVESTMENTS OF $148.1
MILLION
    * ESSA PHARMA INC - ON TRACK TO COMPLETE PHASE 1B
MASOFANITEN
MONOTHERAPY STUDY EVALUATING MASOFANITEN IN PATIENTS WITH
LATE-LINE MCRPC
    * ESSA PHARMA INC - CASH POSITION IS EXPECTED TO BE
SUFFICIENT TO
FUND CURRENT AND PLANNED OPERATIONS THROUGH 2025
    * ESSA PHARMA INC - QTRLY LOSS PER SHARE $0.12

Source text for Eikon:  ID:nCNWswX5ba 
Further company coverage:  EPIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))